Clune & Associates’s Avantis US Equity ETF AVUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$997K Buy
7,787
+16
+0.2% +$2.07K 0.15% 81
2026
Q2
$995K Sell
7,771
-371
-5% -$45.7K 0.15% 83
2026
Q1
$905K Sell
8,142
-2,962
-27% -$339K 0.17% 93
2025
Q4
$1.24M Buy
11,104
+9,021
+433% +$994K 0.27% 79
2025
Q3
$226K Buy
2,083
+3
+0.1% +$315 0.06% 147
2025
Q2
$210K Buy
+2,080
New +$195K 0.06% 148
2025
Q1
– Sell
-2,131
Closed -$207K – 143
2024
Q4
$207K Buy
+2,131
New +$209K 0.07% 133

Other funds holding AVUS

Clune & Associates's AVUS Position: Q3 2026 in Review

Clune & Associates increased its Avantis US Equity ETF (AVUS) stake by 0.21% in Q3 2026, buying an estimated $2.07K and bringing the position to 7,787 shares worth $997K. The position accounts for 0.15% of the portfolio, ranked #81.

Clune & Associates first reported a position in AVUS in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.24M in Q4 2025. 161 funds tracked by Wall St. Rank hold AVUS as of Q3 2026.

  • Clune & Associates held 7,787 shares of Avantis US Equity ETF worth $997K as of Q3 2026.
  • Clune & Associates bought 16 Avantis US Equity ETF shares in Q3 2026, an estimated $2.07K.
  • Avantis US Equity ETF made up 0.15% of Clune & Associates's portfolio in Q3 2026, its #81 holding.
  • Clune & Associates first reported a position in Avantis US Equity ETF in Q4 2024 and has held it in 7 quarters since.
  • Clune & Associates's Avantis US Equity ETF position peaked at $1.24M in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Avantis US Equity ETF as of Q3 2026.

Based on Clune & Associates's 13F filing for Q3 2026, filed 8 Oct 2026.